chr17-38326555-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_001004334.4(GPR179):c.7014G>A(p.Ser2338Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00016 in 1,614,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00065 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )
Consequence
GPR179
NM_001004334.4 synonymous
NM_001004334.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.938
Genes affected
GPR179 (HGNC:31371): (G protein-coupled receptor 179) This gene encodes a member of the glutamate receptor subfamily of G protein-coupled receptors. The encoded protein has an EGF-like calcium binding domain and a seven transmembrane domain in the N-terminal region of the protein. Mutations in this gene are associated with congenital stationary night blindness type 1E. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 17-38326555-C-T is Benign according to our data. Variant chr17-38326555-C-T is described in ClinVar as [Benign]. Clinvar id is 1528954.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-38326555-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.938 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR179 | NM_001004334.4 | c.7014G>A | p.Ser2338Ser | synonymous_variant | 11/11 | ENST00000616987.5 | NP_001004334.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR179 | ENST00000616987.5 | c.7014G>A | p.Ser2338Ser | synonymous_variant | 11/11 | 1 | NM_001004334.4 | ENSP00000483469.2 | ||
GPR179 | ENST00000622573.1 | n.135-862G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000650 AC: 99AN: 152212Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
99
AN:
152212
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000224 AC: 56AN: 249578Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135408
GnomAD3 exomes
AF:
AC:
56
AN:
249578
Hom.:
AF XY:
AC XY:
18
AN XY:
135408
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000109 AC: 160AN: 1461834Hom.: 0 Cov.: 32 AF XY: 0.0000990 AC XY: 72AN XY: 727234
GnomAD4 exome
AF:
AC:
160
AN:
1461834
Hom.:
Cov.:
32
AF XY:
AC XY:
72
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000650 AC: 99AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.000577 AC XY: 43AN XY: 74480
GnomAD4 genome
AF:
AC:
99
AN:
152330
Hom.:
Cov.:
32
AF XY:
AC XY:
43
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
GPR179-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 22, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at